MM
Highly rated in
14
conditions
Highly rated in
14
conditions
Check Dr. Minesh P. Mehta's experience treating your condition:
About Dr. Minesh P. Mehta

Minesh Mehta is a Radiation Oncologist and a Hematologist in Miami, Florida. Mehta has been practicing medicine for over 41 years and is highly rated in 14 conditions, according to our data. His top areas of expertise are Glioma, Gliomatosis Cerebri, Brain Tumor, and Metastatic Brain Tumor. He is licensed to treat patients in Florida. Mehta is currently accepting new patients.

His clinical research consists of co-authoring 386 peer reviewed articles and participating in 16 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Minesh P. Mehta it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Minesh P. Mehta accepts the following insurance:

  •  Ambetter
  •  Bright Health
  •  Molina Healthcare
  •  Aetna
  •  AvMed

Call to see if your plan is accepted.
Locations
8900 N Kendall Dr, Miami, FL 33176
Background & Education
Graduate Institution
Other, 1981
Specialties
Radiation Oncology
Hematology
Oncology
Licenses
Radiology in FL
Hospital Affiliations
Baptist Hospital
Languages Spoken
English
Gujarati
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


15 Clinical Trials

Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
A Phase 2, Single Arm, Multi-center, Open Label Trial Combining Optune With Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma
A Phase II Randomized Trial of Proton Vs. Photon Therapy (IMRT) for Cognitive Preservation in Patients With IDH Mutant, Low to Intermediate Grade Gliomas
Phase II Protocol of Low-Dose Whole Thorax Megavoltage Radiotherapy for Patients With SARS-COV-2 Pneumonia
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases
Phase II Trial Of Optune® Plus Bevacizumab In Bevacizumab-Refractory Recurrent Glioblastoma
Validation of a Novel Thoracic Neoplasm Radiotherapy Image Guidance Technique: A Pilot Study
A Phase I Study of Motexafin Gadolinium (Xcytrin, NSC 695238) and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
A Phase 2a, Multi-Center, Open-Label Study of I-131-CLR1404 in Subjects With Recurrent Glioma
Proposed Pilot Study of Combined Optune+ Bevacizumab, and Hypofractionated Stereotactic Irradiation for Bevacizumab-Naive Recurrent Glioblastoma
View 10 Less Clinical Trials -

386 Total Publications

Adagrasib in Non-Small-Cell Lung Cancer.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors